Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)

HKG:1167 Statistics

Total Valuation

HKG:1167 has a market cap or net worth of HKD 5.85 billion. The enterprise value is 4.76 billion.

Market Cap	5.85B
Enterprise Value	4.76B

Important Dates

The last earnings date was Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1167 has 788.62 million shares outstanding. The number of shares has increased by 0.26% in one year.

Current Share Class	788.62M
Shares Outstanding	788.62M
Shares Change (YoY)	+0.26%
Shares Change (QoQ)	-0.47%
Owned by Insiders (%)	19.65%
Owned by Institutions (%)	15.14%
Float	447.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	35.31
PB Ratio	5.96
P/TBV Ratio	5.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.75
EV / Sales	28.75
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-51.92

Financial Position

The company has a current ratio of 4.89, with a Debt / Equity ratio of 0.16.

Current Ratio	4.89
Quick Ratio	4.87
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-1.76
Interest Coverage	-24.19

Financial Efficiency

Return on equity (ROE) is -15.60% and return on invested capital (ROIC) is -10.77%.

Return on Equity (ROE)	-15.60%
Return on Assets (ROA)	-9.01%
Return on Invested Capital (ROIC)	-10.77%
Return on Capital Employed (ROCE)	-18.20%
Revenue Per Employee	644,748
Profits Per Employee	-644,752
Employee Count	257
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +423.23% in the last 52 weeks. The beta is 0.62, so HKG:1167's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+423.23%
50-Day Moving Average	6.68
200-Day Moving Average	3.72
Relative Strength Index (RSI)	54.98
Average Volume (20 Days)	7,690,550

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1167 had revenue of HKD 165.70 million and -165.70 million in losses. Loss per share was -0.21.

Revenue	165.70M
Gross Profit	165.70M
Operating Income	-216.22M
Pretax Income	-165.70M
Net Income	-165.70M
EBITDA	-202.93M
EBIT	-216.22M
Loss Per Share	-0.21

Balance Sheet

The company has 1.25 billion in cash and 161.84 million in debt, giving a net cash position of 1.09 billion or 1.38 per share.

Cash & Cash Equivalents	1.25B
Total Debt	161.84M
Net Cash	1.09B
Net Cash Per Share	1.38
Equity (Book Value)	982.42M
Book Value Per Share	1.25
Working Capital	1.01B

Cash Flow

In the last 12 months, operating cash flow was -78.88 million and capital expenditures -12.87 million, giving a free cash flow of -91.74 million.

Operating Cash Flow	-78.88M
Capital Expenditures	-12.87M
Free Cash Flow	-91.74M
FCF Per Share	-0.12

Margins

Gross margin is 100.00%, with operating and profit margins of -130.49% and -100.00%.

Gross Margin	100.00%
Operating Margin	-130.49%
Pretax Margin	-100.00%
Profit Margin	-100.00%
EBITDA Margin	-122.47%
EBIT Margin	-130.49%
FCF Margin	n/a

Dividends & Yields

HKG:1167 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.26%
Shareholder Yield	n/a
Earnings Yield	-2.83%
FCF Yield	-1.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1167 has an Altman Z-Score of -1.09 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.09
Piotroski F-Score	3